News

Breakthroughs that will improve animal welfare in cancer research   Cancer is the second leading cause of death worldwide. With the World Health Organization estimating that the number of new cases could rise by 70% over the next two decades, the quest to find effective disease...

“How is technology changing the retail landscape?” As CMO of a tech company, it’s a question that’s always near the top of my mind. The answer is simple - it always has and will continue to transform. However so are so many other factors that sit...

George Thaw, CEO of Fuel3D During the last few years, artificial intelligence (AI) and machine learning have taken a huge leap forwards in transforming healthcare. From diagnosing and treating patients to emerging applications in drug research and discovery, the potential is truly vast. McKinsey[1] estimates that...

For decades handheld callipers have been used as the standard method to measure the volume of subcutaneous mice tumours in preclinical oncology research. Although the use of animals in modern medicine and biology is essential, researchers are actively working to reduce the numbers used and...

Fuel3D™, a world-leading provider of innovative 3D scanning solutions, will be showcasing how BioVolume® enables pharmaceutical companies, CROs and academic institutions to standardise the measurement of subcutaneous tumours in preclinical oncology research, at the IAT Congress 2018. Developed in partnership with a global pharmaceutical company...

Contact Us
Thanks for your message
We'll be in touch shortly

captcha

captcha

7


captcha